Search details
1.
Punctuated evolution of prostate cancer genomes.
Cell
; 153(3): 666-77, 2013 Apr 25.
Article
in English
| MEDLINE | ID: mdl-23622249
2.
Optimized high-throughput screening of non-coding variants identified from genome-wide association studies.
Nucleic Acids Res
; 51(3): e18, 2023 02 22.
Article
in English
| MEDLINE | ID: mdl-36546757
3.
H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
Am J Hum Genet
; 108(12): 2284-2300, 2021 12 02.
Article
in English
| MEDLINE | ID: mdl-34822763
4.
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Proc Natl Acad Sci U S A
; 111(51): E5564-73, 2014 Dec 23.
Article
in English
| MEDLINE | ID: mdl-25512523
5.
Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients.
Res Sq
; 2023 Jan 10.
Article
in English
| MEDLINE | ID: mdl-36711812
6.
Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary.
Nat Med
; 29(8): 2057-2067, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37550415
7.
The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer.
Nat Commun
; 14(1): 8084, 2023 Dec 06.
Article
in English
| MEDLINE | ID: mdl-38057321
8.
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
Nat Commun
; 14(1): 346, 2023 01 21.
Article
in English
| MEDLINE | ID: mdl-36681680
9.
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.
Cancer Discov
; 13(3): 632-653, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36399432
10.
Liquid biopsy epigenomic profiling for cancer subtyping.
Nat Med
; 29(11): 2737-2741, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37865722
11.
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.
Nat Commun
; 13(1): 2282, 2022 04 27.
Article
in English
| MEDLINE | ID: mdl-35477723
12.
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer.
NPJ Precis Oncol
; 6(1): 80, 2022 Nov 02.
Article
in English
| MEDLINE | ID: mdl-36323882
13.
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.
Nat Genet
; 54(5): 670-683, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35468964
14.
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation.
Nat Genet
; 54(9): 1364-1375, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36071171
15.
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
Nat Commun
; 13(1): 7367, 2022 11 30.
Article
in English
| MEDLINE | ID: mdl-36450752
16.
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.
Clin Cancer Res
; 28(5): 928-938, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-34907080
17.
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer.
Cell Rep
; 38(8): 110417, 2022 02 22.
Article
in English
| MEDLINE | ID: mdl-35196489
18.
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies.
Elife
; 112022 05 12.
Article
in English
| MEDLINE | ID: mdl-35550030
19.
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.
Cancer Res
; 82(16): 2848-2859, 2022 08 16.
Article
in English
| MEDLINE | ID: mdl-35731919
20.
Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence.
Cancer Discov
; 12(9): 2074-2097, 2022 09 02.
Article
in English
| MEDLINE | ID: mdl-35754340